Similar articles for PMID: 32887760

Year	Number of Results
2003	1
2004	2
2005	2
2006	1
2007	2
2009	2
2011	3
2012	3
2013	5
2014	10
2015	9
2016	14
2017	8
2018	13
2019	16
2020	14
2021	19
2022	15

1

Dose Optimization in ¹⁸F-FDG PET Based on Noise-Equivalent Count Rate Measurement and Image Quality Assessment.

Rana N, Kaur M, Singh H, Mittal BR. Rana N, et al. J Nucl Med Technol. 2021 Mar;49(1):49-53. doi: 10.2967/jnmt.120.250282. Epub 2020 Sep 4. J Nucl Med Technol. 2021. PMID: 32887760 Free article.

2

Effects of injected dose, BMI and scanner type on NECR and image noise in PET imaging.

Chang T, Chang G, Kohlmyer S, Clark JW, Rohren E, Mawlawi OR. Chang T, et al. Phys Med Biol. 2011 Aug 21;56(16):5275-85. doi: 10.1088/0031-9155/56/16/013. Epub 2011 Jul 26. Phys Med Biol. 2011. PMID: 21791730

3

Image quality and lesion detectability in low-dose pediatric ¹⁸F-FDG scans using total-body PET/CT.

Zhao YM, Li YH, Chen T, Zhang WG, Wang LH, Feng J, Li C, Zhang X, Fan W, Hu YY. Zhao YM, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3378-3385. doi: 10.1007/s00259-021-05304-4. Epub 2021 Mar 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 33738519

4

Relating¹⁸F-FDG image signal-to-noise ratio to time-of-flight noise-equivalent count rate in total-body PET using the uEXPLORER scanner.

Leung EK, Abdelhafez YG, Berg E, Xie Z, Zhang X, Bayerlein R, Spencer B, Li E, Omidvari N, Selfridge A, Cherry SR, Qi J, Badawi RD. Leung EK, et al. Phys Med Biol. 2022 Jun 10;67(12):10.1088/1361-6560/ac72f1. doi: 10.1088/1361-6560/ac72f1. Phys Med Biol. 2022. PMID: 35609588

5

Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.

Tan H, Sui X, Yin H, Yu H, Gu Y, Chen S, Hu P, Mao W, Shi H. Tan H, et al. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1966-1975. doi: 10.1007/s00259-020-05091-4. Epub 2020 Nov 27. Eur J Nucl Med Mol Imaging. 2021. PMID: 33244618

6

Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by ¹⁸F-FDG total-body PET/CT imaging?

Xiao J, Yu H, Sui X, Hu Y, Cao Y, Liu G, Zhang Y, Hu P, Wang Y, Li C, Xu B, Shi H. Xiao J, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):269-278. doi: 10.1007/s00259-021-05462-5. Epub 2021 Jun 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 34185138 Clinical Trial.

7

Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.

Tan H, Mao W, Cao Y, Cai D, Sui X, Qi C, Yu H, Zhang Y, Shi H. Tan H, et al. Nucl Med Commun. 2022 Aug 1;43(8):928-936. doi: 10.1097/MNM.0000000000001589. Epub 2022 May 30. Nucl Med Commun. 2022. PMID: 35634804

8

Clinical NECR in 18F-FDG PET scans: optimization of injected activity and variable acquisition time. Relationship with SNR.

Carlier T, Ferrer L, Necib H, Bodet-Milin C, Rousseau C, Kraeber-Bodéré F. Carlier T, et al. Phys Med Biol. 2014 Nov 7;59(21):6417-30. doi: 10.1088/0031-9155/59/21/6417. Epub 2014 Oct 8. Phys Med Biol. 2014. PMID: 25295879

9

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low ¹⁸F-FDG Activity.

Hu Y, Liu G, Yu H, Wang Y, Li C, Tan H, Chen S, Gu J, Shi H. Hu Y, et al. J Nucl Med. 2022 Jun;63(6):959-965. doi: 10.2967/jnumed.121.262038. Epub 2021 Sep 30. J Nucl Med. 2022. PMID: 34593593 Free PMC article.

10

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed